Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nirmatrelvir/Ritonavir and molnupiravir: an update on COVID-19 antivirals in the Omicron era
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume -, Issue -, Pages 1-3
Publisher
Informa UK Limited
Online
2023-10-06
DOI
10.1080/17512433.2023.2267973
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PAXLOVID™: A Regulatory Gamble
- (2023) Miloš D. Miljković et al. AMERICAN JOURNAL OF MEDICINE
- Nirmatrelvir–ritonavir for the treatment of COVID‐19 patients: A systematic review and meta‐analysis
- (2023) Huzaifa A. Cheema et al. JOURNAL OF MEDICAL VIROLOGY
- Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use
- (2023) Robbert Visscher et al. European Journal of Hospital Pharmacy-Science and Practice
- Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
- (2023) Jiao Liu et al. The Lancet Regional Health Western Pacific
- Efficacy and Safety of Favipiravir for the Treatment of COVID-19 Outpatients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- (2023) Huzaifa Ahmad Cheema et al. AMERICAN JOURNAL OF THERAPEUTICS
- Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
- (2022) Jennifer Hammond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Making Statistical Sense of the Molnupiravir MOVe-OUT Clinical Trial
- (2022) Kristian Thorlund et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Efficacy and safety of molnupiravir for COVID-19 patients
- (2022) Maurish Fatima et al. European Journal of Internal Medicine
- Identification of Drug Interaction Adverse Events in Patients With COVID-19
- (2022) Valeria Conti et al. JAMA Network Open
- COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed
- (2022) Nadir Yalcin et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Paxlovid: Mechanism of Action, Synthesis, and In Silico Study
- (2022) Mahrokh Marzi et al. Biomed Research International
- Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis
- (2022) Huzaifa Ahmad Cheema et al. JOURNAL OF INFECTION
- Covid-19: Results from India’s 12 molnupiravir clinical trials remain unpublished
- (2022) Elisabeth Mahase BMJ-British Medical Journal
- No evidence of clinical efficacy of famotidine for the treatment of COVID-19: a systematic review and meta-analysis
- (2022) Huzaifa Ahmad Cheema et al. JOURNAL OF INFECTION
- Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
- (2022) Christopher C Butler et al. LANCET
- Molnupiravir: From Hope to Epic Fail?
- (2022) Daniele Focosi Viruses-Basel
- What is the place in therapy for nirmatrelvir/ritonavir?
- (2022) Todd C Lee et al. BMJ Evidence-Based Medicine
- Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
- (2021) Angélica Jayk Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
- (2020) Craig R. Rayner et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation